trending Market Intelligence /marketintelligence/en/news-insights/trending/E0tjo7RWNmFqYDT4mHbp1Q2 content esgSubNav
In This List

BioPharmX receives non-compliance notice from NYSE

Blog

Baird Research is Now Exclusively Available in S&P Global’s Aftermarket Research Collection

Blog

Japan M&A By the Numbers: Q4 2023

Blog

Essential IR Insights Newsletter Fall - 2023

Case Study

A Corporation Clearly Pinpoints Activist Investor Activity


BioPharmX receives non-compliance notice from NYSE

BioPharmX Corp. received a non-compliance notice from the NYSE American LLC on Dec. 1 because its common stock was selling for a low price per share for a substantial period of time.

The company has until June 1, 2018 to effect a reverse stock split or show a sustained price improvement to remain listed on the exchange.

The notice doesn't have an immediate effect on BioPharmX's shares and they will continue trading until the given period.